Loading…
The Bactericidal and Antibiofilm Effects of New Liposomes Containing Vancomycin Formulation Against Clinical Biofilm Positive Staphylococcus aureus Isolates
The aim of present study was to prepare liposomes containing vancomycin (Lipo-VAN) formulation, and to evaluate the anti-biofilm effect of Lipo-VAN on the expression of icaA genes in clinical strains of Staphylococcus aureus . Lipo-VAN was synthesized using thin-layer hydration method. Formulation n...
Saved in:
Published in: | Applied biochemistry and microbiology 2023-12, Vol.59 (6), p.824-832 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The aim of present study was to prepare liposomes containing vancomycin (Lipo-VAN) formulation, and to evaluate the anti-biofilm effect of Lipo-VAN on the expression of
icaA
genes in clinical strains of
Staphylococcus aureus
. Lipo-VAN was synthesized using thin-layer hydration method. Formulation no. 3 (F3) with the lowest size of 178.1 nm and polydispersity index value of 0.163 and with the highest efficiency for entrapping drug (65.49%) was selected as an optimal formulation. The formulations were tested for bactericidal and antibiofilm effects against
S. aureus
strains. The MIC and MBC obtained for the Lipo-VAN against clinical strains were 7.81–62.5 and 15.62–125 µg/mL, respectively. In addition, the reduction in biofilm formation in strains treated with Lipo-VAN was more significant rather than in the VAN-treated and control groups, which was demonstrated with down-regulation of
icaA
gene expression. Lipo-VAN formulation exhibited elevated antimicrobial and anti-biofilm activity against clinical
S. aureus
strains. |
---|---|
ISSN: | 0003-6838 1608-3024 |
DOI: | 10.1134/S0003683823060157 |